Abstract
Beat AML 1.0 is a collaborative research program involving 11 academic medical centers who worked collectively to better understand drugs and drug combinations that should be prioritized for further development within clinical and/or molecular subsets of acute myeloid leukemia (AML) patients. Beat AML 1.0 provides the largest-to-date dataset on primary acute myeloid leukemia samples offering genomic, clinical, and drug response. This dataset contains open Clinical Supplement and RNA-Seq Gene Expression Quantification data. This dataset also contains controlled Whole Exome Sequencing (WXS) and RNA-Seq Aligned Reads, WXS Annotated Somatic Mutat
Catalogue metadata
- Record ID
- AISLI-R-ED272377F1866F4113F4
- Type
- Datasets
- Source catalogue
- registry.opendata.aws
- الموضوع
- 生命科学与生物医学
- شروط الاستخدام
- NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies